Eric Hostetler, PhD, joined Merck’s imaging department in 2000. Since then, he has had various roles in imaging at Merck, including director of the PET tracer group. Dr. Hostetler led or contributed to the discovery of novel PET tracers for 12 different targets, primarily for the purpose of guiding neuroscience drug development. He is currently the head of translational imaging biomarkers at Merck, with a mission to discover, develop and implement novel imaging biomarkers to impact drug discovery and development.
Dr. Hostetler obtained his doctorate from the University of Illinois, Urbana-Champaign. He completed organic chemistry graduate work in the laboratory of Dr. John Katzenellenbogen, where he developed novel chemistry methods for the incorporation of positron-emitting radioisotopes into small molecules. Dr. Hostetler continued in the field of molecular imaging with a postdoctoral appointment at the Washington University St. Louis School of Medicine in the Mallinckrodt Institute of Radiology.